Giant Cell Arteritis Clinical Trials

137 clinical trials for Giant Cell Arteritis across international registries, including 39 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis — RECRUITING
• Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis — RECRUITING · PHASE2
• Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients — RECRUITING · NA
• Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering — RECRUITING · PHASE3
• Disease Activity Monitoring in Patients With Giant Cell Arteritis Study — RECRUITING
• Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis — RECRUITING
• A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART) — RECRUITING · PHASE3
• A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis — RECRUITING · PHASE2
• The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis. — RECRUITING
• Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis — RECRUITING
• Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency — RECRUITING · PHASE4
• Rheumatology Patient Registry and Biorepository — RECRUITING
• Abatacept for the Treatment of Giant Cell Arteritis — RECRUITING · PHASE3
• VCRC Tissue Repository — RECRUITING
• One-Time DNA Study for Vasculitis — RECRUITING
• Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) — RECRUITING · PHASE2
• Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA) — RECRUITING
• Giant Cell Arteritis - Ways to Precision Medicine — RECRUITING
• Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment — RECRUITING · PHASE4
• Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) — RECRUITING
• oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound — RECRUITING · NA
• Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ) — RECRUITING
• Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy — RECRUITING
• Optic Nerve Sheath Ultrasound in Giant Cell Arteritis — RECRUITING
• Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis — RECRUITING
• Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic — RECRUITING
• AYLo - AutoimmunitY and Loss of y — RECRUITING
• Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases — RECRUITING
• Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis — RECRUITING
• Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) — RECRUITING
• Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases — RECRUITING · PHASE4
• TocILizumab in aorTitis in GCA (TILT) — RECRUITING
• Visual Involvement in Giant Cell Arteritis — RECRUITING
• Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim) — RECRUITING
• Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis — RECRUITING
• DANIsh VASculitis Database (DANIVAS) — RECRUITING
• A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF ABATACEPT (CTLA4-IG IN GIANT CELL ARTERITIS (ABAGART)) — RECRUITING
• A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND,PROOF-OF-CONCEPT STUDY TO EVALUATE GUSELKUMAB FOR THE TREATMENT OF PARTICIPANTS WITH NEW-ONSET OR RELAPSING GIANT CELL ARTERITIS — RECRUITING · PHASE2
• A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF OF CONCEPT STUDY OF THE EFFICACY AND THE SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF PATIENTS WITH GIANT CELL ARTERITIS — RECRUITING
• Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research — NOT_YET_RECRUITING
• Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON) — NOT_YET_RECRUITING · NA
• Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA) — NOT_YET_RECRUITING
• PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS — ACTIVE_NOT_RECRUITING
• Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study. — NOT_YET_RECRUITING · NA
• Bosentan in the Treatment of Giant Cell Arteritis — NOT_YET_RECRUITING · PHASE2
• TocilizuMab discontinuAtion in GIant Cell Arteritis — ACTIVE_NOT_RECRUITING · PHASE3
• Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone — NOT_YET_RECRUITING · PHASE3
• Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica. — COMPLETED
• MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial — ACTIVE_NOT_RECRUITING · PHASE3
• MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial — TERMINATED · PHASE3

Refine this search